Pulmonary drug delivery: Novel pharmaceutical technologies breathe new life into the lungs

PDA Journal of Pharmaceutical Science and Technology

Volumn 65, Issue 5, 2011, Pages 513-534

  Nanjwade, Basavaraj K ^a   Adichwal, Sagar A ^a   Gaikwad, Kishori R ^a   Parikh, Kemy A ^a   Manvi, F V ^a  

^a K L E S S COLLEGE OF PHARMACY   (India)

Author keywords

Carriers for pulmonary drug delivery; Delivery devices; Inhalation; Proteins and peptides; Pulmonary drug delivery; Targeting

Indexed keywords

ADHESIVE AGENT; BECLOMETASONE DIPROPIONATE; CHLOROFLUOROCARBON; CYCLODEXTRIN; CYCLOSPORIN A; DIPALMITOYLPHOSPHATIDYLGLYCEROL; EFLORNITHINE; FLUOROURACIL; GLYCERYL TRINITRATE; HEPARIN; HYALURONIC ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON REGULATORY FACTOR; ISONIAZID; ISOSORBIDE; LOW MOLECULAR WEIGHT HEPARIN; LUNG SURFACTANT; MACROGOL; MICROSPHERE; NANOPARTICLE; POLYGLACTIN; PROSTACYCLIN; PYRAZINAMIDE; RECOMBINANT EPIDERMAL GROWTH FACTOR; RIFAMPICIN; SALBUTAMOL; SOLID LIPID NANOPARTICLE; SUPEROXIDE DISMUTASE; URIDINE TRIPHOSPHATE;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; AEROSOL; ANGINA PECTORIS; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPRESSED AIR; CYSTIC FIBROSIS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TARGETING; GENE THERAPY; HUMAN; HYPOXEMIA; LIPOSOMAL DELIVERY; LUNG CIRCULATION; LUNG EMBOLISM; LUNG TRANSPLANTATION; LUNG TUMOR; MEAN RESIDENCE TIME; METERED DOSE INHALER; MICELLE; MICROBUBBLE; NANOENCAPSULATION; NEBULIZER; NONHUMAN; OXYGENATION; POWDER INHALER; REPERFUSION INJURY; RESPIRATORY AIRFLOW; REVIEW; TREATMENT OUTCOME; TUBERCULOSIS; XEROSTOMIA; DEVICES; INHALATIONAL DRUG ADMINISTRATION; LUNG; PHARMACEUTICS;

ADMINISTRATION, INHALATION; DRUG DELIVERY SYSTEMS; LUNG; METERED DOSE INHALERS; NEBULIZERS AND VAPORIZERS; TECHNOLOGY, PHARMACEUTICAL;

EID: 83755178624     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: 10.5731/pdajpst.2011.00704     Document Type: Review

References (113)

1. Bivas-Benita, M.; Zwier, R. I.; Junginger, H. E.; Borchard, G. Non-invasive pulmonary aerosol delivery in mice by the endotracheal route. Eur. J. Pharm. Biopharm. 2005, 61 (3), 214-218. (Pubitemid 41427629)
2. Smyth, H. D.; Hickey, A. J. Carriers in drug powder delivery: implications for inhalation system design. Am. J. Drug Deliv. 2005, 3 (2), 117-132. (Pubitemid 41018283)
3. Jaspart, S.; Bertholet, P.; Delattre, L.; Evrard, B. Study of Solid Lipid Microparticles as Sustained Release Delivery System for Pulmonary Administration. Presented at the 15th International Symposium on Microencapsulation, Parma, Italy, 2005, pp 241-242.
4. Wamsley, A. Ligand-Based Targeting Approaches to Drug Delivery. In Design of Con-trolled Release Drug Delivery Systems; Li, X., Jasti, B. R., Eds. The McGraw-Hill Companies, Inc.: New York, 2006; pp 377-378.
5. Smyth, H.; Saleem, I.; Donovan, M. Emerging carriers for pulmonary drug delivery. AAPS Newsmagazine 2006, August, 12-15.
6. Kokate, K.; Marasanapalle, V. O.; Jasti, B. R.; Li, X. Physiological and Biochemical Barriers to Drug Delivery. In Design of Controlled Release Drug Delivery Systems; Li, X., Jasti, B. R., Eds.; The McGraw-Hill Companies, Inc.: New York, 2006; pp 63-64.
7. Tong, H. H. Y.; Chow, A. H. L. Control of physical forms of drug particles for pulmonary delivery by spray drying and supercritical fluid processing. KONA 2006, 24, 27-40.
8. Agu, R. U.; Ugwoke, M. I.; Armand, M.; Kinget, R.; Verbeke, N. The lung as a route for systemic delivery of therapeutic proteins and peptides. Respir. Res. 2001, 2 (4), 198-209. (Pubitemid 34187927)
9. Labiris, N. R.; Bosco, A. P.; Dolovich, M. B. Aerosols as Drug Carriers. In Nanoparticulates as Drug Carriers; Torchilin, V. P., Ed.; Imperial College Press: London, 2006; pp 367-395.
10. Folkesson, H. G.; Matthey, M. A.; Westrom, B. R.; Kim, K. J.; Karlsson, B. W.; Hastings, R. H. Alveolar epithelial clearance of protein. Appl. Physiol. 1996, 80 (5), 1431-1445. (Pubitemid 26143889)
11. Sélam, J. L. Inhaled insulin: promises and concerns. J. Diabetes Sci. Technol. 2008, 2 (2), 311-315.
12. ACGIH. Threshold Limit Values and Biological Exposure Indices; ACGIH: Cincinnati, OH, 1997.
13. Cryan, S. A. Carrier-based strategies for targeting protein and peptide drugs to the lungs. AAPS J. 2005, 7 (1), E20-E41.
14. Mueller-Walz, R. Device Controlled Delivery of Powders. In Design of Controlled Release Drug Delivery Systems; Li, X., Jasti, B. R., Eds.; The McGraw-Hill Companies, Inc.: New York, 2006; pp 231-268.
15. Telko, M. J.; Hickey, A. J. Dry powder inhaler formulation. Respiratory Care 2005, 50 (9), 1209-1227. (Pubitemid 46187575)
16. Wetterlin, K. Turbuhaler: a new powder inhaler for administration of drugs to the airways. Pharm. Res. 1998, 5 (8), 506-508.
17. Prime, D.; Atkins, P. J.; Slater, A.; Sumby, B. Review of dry powder inhalers. Adv. Drug Del. Rev. 1997, 26 (1), 51-58. (Pubitemid 27288484)
18. Newman, S. P. Principles of metered-dose inhaler design. Respiratory Care 2005, 50 (9), 1177-1190.
19. Smyth, H. D. The influence of formulation variables on the performance of alternative propellant- driven metered dose inhalers. Adv. Drug Deliv. Rev. 2003, 55 (7), 807-828. (Pubitemid 36776795)
20. Noakes, T. Medical aerosol propellants. J. Fluorine Chem. 2002, 118 (1-2), 35-45.
21. Hallworth, G. W. The Formulation and Evaluation of Pressurised Metered Dose Inhalers. In Drug Delivery to the Respiratory Tract; Ganderton, D., Jones, T., Eds.; Ellis Horwood: Chichester, U.K., 1987; pp 87-118.
22. Lenney, J.; Innes, J. A.; Crompton, G. K. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. Respir. Med. 2000, 94 (5), 496-500. (Pubitemid 30353008)
23. Newman, S. P.; Weisz, A. W.; Talaee, N.; Clarke, S. W. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax 1991, 46 (10), 712-716.
24. Newman, S. P.; Steed, K. P.; Hooper, G.; Jones, J. I.; Upchurch, F. C. Improved targeting of beclomethasone dipropionate (250 micrograms metered dose inhaler) to the lungs of asthmatics with the Spacehaler. Respir. Med. 1999, 93 (6), 424-431. (Pubitemid 29265354)
25. Leach, C. L.; Davidson, P. J.; Boudreau, R. J. Improved airway targeting with the CFC-free HFA-beclomethasone metered dose inhaler com- pared with CFC beclomethasone. Eur. Respir. J. 1998, 12 (6), 1346-1353. (Pubitemid 29011427)
26. Dickinson, P. A.; Howells, S. W.; Kellaway, I. W. Novel nanoparticles for pulmonary drug administration. J. Drug Target 2001, 9 (4), 295-302. (Pubitemid 32776364)
27. Kraft, W. K.; Steiger, B.; Beussink, D.; Quiring, J. N.; Fitzgerald, N.; Greenberg, H. E.; Waldman, S. A. The pharmacokinetics of nebulized nanocrystal budesonide suspension in healthy volunteers. J Clin. Pharmacol. 2004, 44 (1), 67-72. (Pubitemid 38005095)
28. Videira, M. A.; Botelho, M. F.; Santos, A. C.; Gouveia, L. F.; Pedrosos De Lima, J. J; Almeida, A. J. Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles. J. Drug Target 2002, 10 (8), 607-613. (Pubitemid 36124361)
29. Lamm, M. E. Interactions of antigens and antibodies at mucosal surfaces. Ann. Rev. Microbiol. 1997, 51, 311-340. (Pubitemid 27433052)
30. Vila, A.; Sanchez, A.; Janes, K.; Behrens, I.; Kissel, T.; Vila, J. L.; Alonso, M. J. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur. J. Pharm. Biopharm. 2004, 57 (1), 123-131. (Pubitemid 38058811)
31. Vila, A.; Sanchez, A.; Evora, C.; Soriano, I.; Vila, J. J.; Alonso, M. J. PEG-PLA nanoparticles as carriers for nasal vaccine delivery. Aerosol Med. 2004, 17 (2), 174-185. (Pubitemid 38955679)
32. Jung, T.; Kamm, W.; Breitenbach, A.; Hungerer, K. D. Hundt, E.; Kissel, T. Tetanus toxoid loaded nanoparticles from sulfobutylated poly- (vinyl alcohol)-graftpoly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice. Pharm. Res. 2001, 18 (3), 352-360.
33. Pinto-Alphandary, P.; Andremont, A.; Couvreur, P. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. Int. J. Antimicrobial Agents 2000, 13 (3), 155-168.
34. Kumar, M.; Kong, X.; Behera, A. K.; Hellermann, G. R.; Lockey, R. F.; Mohapatra, S. S. Chitosan IFN-γ-pDNA nanoparticle (CIN) therapy for allergic asthma. Gen. Vacc. Ther. 2003, 1 (1), 3-11.
35. Zeng, A.; Martin, C. G.; Marriott, C. The controlled delivery of drugs to the lung. Int. J. Pharm. 1995, 124 (2), 149-164.
36. Suarez, S.; Gonzalez-Rothi, R. J.; Schreier, H.; Hochhaus, G. Effect of dose and release rate on pulmonary targeting of liposomal triamcinolone acetonide phosphate. Pharm. Res. 1998, 15 (3), 461-465. (Pubitemid 28175129)
37. Fielding, R.; Ahra, R. M. Factors affecting the release rate of terbutaline from liposome formulations after intratracheal instillation in the guinea pig. Pharm. Res. 1992, 9 (2), 220-223.
38. Canonico, A. E.; Plitman, J. D.; Conary, J. T.; Meyrick, B. O.; Brigham, K. L. No lung toxicity after repeated aerosol or intravenous delivery of plasmidcationic liposome complexes. J. Appl. Physiol. 1994, 77 (1), 415-419. (Pubitemid 24226162)
39. Eastman, S. J.; Tousignant, J. D.; Lukason, M. J.; Murray, H.; Siegel, C. S.; Constantino, P.; Harris, D. J.; Cheng, S. H.; Scheule, R. K. Optimization of formulations and conditions for the aerosol delivery of functional cationic lipid:DNA complex. Hum. Gene Ther. 1997, 8 (3), 313-322. (Pubitemid 27412267)
40. McLachlan, G.; Davidson, D. J.; Stevenson, B. J.; Dickinson, P.; Davidson-Smith, H.; Dorin, J. R.; Porteous, D. J. Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy. Gene Ther. 1995, 2 (9), 614-622.
41. McCluskie, M. J.; Chu, Y.; Xia, J. L.; Jessee, J.; Gebyehu, G.; Davis, H. L. Direct gene transfer to the respiratory tract of mice with pure plasmid and lipid-formulated DNA. Antisense Nucleic Acid Drug Dev. 1998, 8 (5), 401-414. (Pubitemid 28510826)
42. Zou, Y.; Zong, G.; Ling, Y. H.; Perez-Soler, R. Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer. Cancer Gene Ther. 2000, 7 (5), 683-696. (Pubitemid 30314053)
43. Stribling, S.; Brunette, E.; Liggitt, D.; Gaensler, K.; Debs, R. Aerosol gene delivery in vivo. Proc. Natl. Acad. Sci. USA 1992, 89 (23), 11277-11281.
44. Schreier, H.; Mobley, W. C.; Concessio, N.; Hickey, A. J.; Niven, R. W. Formulation and in vitro performance of liposome powder aerosols. STP Pharma Sciences 1994, 4 (1), 38-44. (Pubitemid 24058058)
45. Joshi, M.; Misra, A. Dry powder inhalation of liposomal Ketotifen fumarate: formulation and characterization. Int. J. Pharm. 2001, 223 (1-2), 15-27. (Pubitemid 32640874)
46. Skalko-Basnet, N.; Pavelic, Z.; Becirevic-Lacan, M. Liposomes containing drug and cyclodextrin prepared by the one-step spray-drying method. Drug Dev. Ind. Pharm. 2000, 26 (12), 1279- 1284.
47. Seville, P. C.; Kellaway, I. W.; Birchall, J. C. Preparation of dry powder dispersions for non-viral gene delivery by freeze-drying and spraydrying. J. Gene Med. 2002, 4 (4), 428-437. (Pubitemid 40277180)
48. Kim, J. C.; Kim, J. D. Preparation by spray-drying of amphotericin Bphospholipid composite particles and their anticellular activity. Drug Deliv. 2001, 8 (3), 143-147.
49. Letsou, G. V.; Safi, H. J.; Reardon, M. J.; Ergenoglu, M.; Li, Z.; Klonaris, C. N.; Baldwin, J. C.; Gilbert, B. E.; Waldrep, J. C. Pharmacokinetics of liposomal aerosolized cyclosporine A for pulmonary immunosuppression. Ann. Thorac. Surg. 1999, 68 (6), 2044-2048. (Pubitemid 30027822)
50. Liu, F. Y.; Shao, Z.; Kildsig, D. O.; Mitra, A. K. Pulmonary delivery of free and liposomal insulin. Pharm. Res. 1993, 10 (2), 228-232. (Pubitemid 23041736)
51. Padmanabhan, R. V.; Gudapaty, R.; Liener, E. E.; Schwartz, B. A.; Hoidal, J. R. Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalase. Am. Rev. Respir. Dis. 1985, 132 (1), 164-167.
52. Khanna, C.; Hasz, D. E.; Klausner, J. S.; Anderson, P. M. Aerosol delivery of interleukin 2 liposomes is nontoxic and biologically effective: canine studies. Clin. Cancer Res. 1996, 2 (4), 721-734. (Pubitemid 26135341)
53. Griffiths, G. D.; Phillips, G. J.; Bailey, S. C. Comparison of the quality of protection elicited by toxoid and peptide liposomal vaccine formulations against ricin as assessed by markers of inflammation. Vaccine 1999, 17 (20-21), 2562-2568. (Pubitemid 29314449)
54. Colletier, J. P; Chaize, B.; Winterhalter, M.; Fournier, D. Protein encapsulation in liposomes: efficiency depends on interactions between protein and phospholipid bilayer. BMC Biotechnol. 2002, 2 (9), 1-8.
55. Galovic, R. R.; Barisic, K.; Pavelic, Z.; Zanic, G. T.; Cepelak, I.; Filipovic-Grcic, J. High efficiency entrapment of superoxide dismutase into mucoadhesive chitosan-coated liposomes. Eur. J. Pharm. Sci. 2002, 15 (5), 441-448.
56. Wagner, A.; Vorauer-Uhl, K.; Kreismayr, G.; Katinger, H. Enhanced protein loading into liposomes by the multiple crossflow injection technique. J. Liposome Res. 2002, 12 (3), 271-283. (Pubitemid 35403646)
57. Mozafari, M. R.; Reed, C. J.; Rostron, C.; Kocum, C.; Piskin, E. Formation and characterisation of non-toxic anionic liposomes for delivery of therapeutic agents to the pulmonary airways. Cell Mol. Biol. Lett. 2002, 7 (2), 243-244.
58. Mozafari, M. R.; Hasirci, V. Mechanism of calcium ion induced multilamellar vesicle-DNA interaction. J. Microencapsul. 1998, 15 (1), 55-65. (Pubitemid 28031790)
59. Mozafari, M. R.; Zareie, M. H.; Piskin, E.; Hasirci, V. Formation of supramolecular structures by negatively charged liposomes in the presence of nucleic acids and divalent cations. Drug Deliv. 1998, 5 (2), 135-141. (Pubitemid 28313923)
60. Zareie, M. H.; Mozafari, M. R.; Hasirci, V.; Piskin, E. Scanning tunnelling microscopy investigation of liposome-DNA-Ca2+ complexes. J. Liposome Res. 1997, 7 (4), 491-502.
61. Bot, A. I.; Tarara, T. E.; Smith, D. J.; Bot, S. R.; Woods, C. M.; Weers, J. G. Novel lipid-based hollow-porous microparticles as a platform for immunoglobulin delivery to the respiratory tract. Pharm. Res. 2000, 17 (3), 275-283. (Pubitemid 30225130)
62. Hutchinson, F. G.; Furr, B. J. Biodegradable polymers for controlled release of peptides and proteins. Horiz. Biochem. Biophys. 1989, 9, 111-129.
63. Ehrhardt, C.; Fiegel, J.; Fuchs, S.; Abu-Dahab, R.; Schaefer, U. F.; Hanes, J.; Lehr, C. M. Drug absorption by the respiratory mucosa: cell culture models and particulate drug carriers. J. Aerosol Med. 2002, 15 (2), 131-139.
64. Evora, C.; Soriano, I.; Rogers, R. A.; Shakesheff, K. N.; Hanes, J.; Langer, R. Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine. J. Controlled Release 1998, 51 (2-3), 143-152. (Pubitemid 28252865)
65. Morimoto, K.; Katsumata, H.; Yabuta, T.; Iwanaga, K.; Kakemi, M.; Tabata, Y.; Ikada, Y. Gelatin microspheres as a pulmonary delivery system: evaluation of salmon calcitonin absorption. J. Pharm. Pharmacol. 2000, 52 (6), 611-617. (Pubitemid 30410073)
66. Scott, T.; Sullivan, A.; Proos, R. Novel Technology for Fabrication of Therapeutic Microspheres for Pulmonary Delivery. In Respiratory Drug Delivery VIII; Dalby, R., Bryon, P. R., Peart, J., Farr, S. J., Eds.; Davis Horwood International Publishing: Raleigh, NC, 2002; pp 435-437.
67. Dhiman, N.; Khuller, G. K. Protective efficacy of mycobacterial 71-kDa cell wall associated protein using poly (DL-lactide-co-glycolide) microparticles as carrier vehicles. FEMS Immunol. Med. Microbiol. 1998, 21 (1), 19-28. (Pubitemid 28258964)
68. Kawashima, Y.; Yamamoto, H.; Takeuchi, H.; Fujioka, S.; Hino, T. Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. J. Controlled Release 1999, 62 (1-2), 279-287. (Pubitemid 29486508)
69. Edwards, D. A.; Hanes, J.; Caponetti, G.; Hrkach, J.; Ben-Jebria, A.; Eskew, M. L.; Mintzes, J.; Deaver, D.; Lotan, N.; Langer, R. Large porous particles for pulmonary drug delivery. Science 1997, 276 (5320), 1868-1871. (Pubitemid 27443665)
70. Brown, L. R.; Rashba-Step, J.; Scott, T.; Yuanxi, Q.; Rulon, P. W.; McGeehan, J.; Hogeland, K.; Fortier, R.; Sullivan, A.; Proos, R.; Peters, L. Pulmonary Delivery of Novel Insulin Microspheres. In Respiratory Drug Delivery XIII; Dalby, R., Byron, P. R., Peart, J., Farr, S. J., Eds.; Davis Horwood International Publishing: Raleigh, NC, 2002; pp 431-433.
71. Surendrakumar, K.; Martyn, G. P.; Hodgers, E. C. M.; Jansen, M.; Blair, J. A. Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs. J. Controlled Release 2003, 91 (3), 385-394. (Pubitemid 36980658)
72. Pfutzner, A.; Mann, A. E.; Steiner, S. S. Technosphere/ insulin - a new approach for effective delivery of human insulin via the pulmonary route. Diabetes Technol. Ther. 2002, 4 (5), 589- 594.
73. Steiner, S.; Pfutzner, S.; Wilson, B. R.; Harzer, O.; Heinemann, L.; Rave, K. Technosphere/insulin - proof of concept study with a new insulin formulation for pulmonary delivery. Exp. Clin. Endocrinol. Diabetes 2002, 110, 17-21. (Pubitemid 34136277)
74. Garcia-Contreras, L.; Morcol, T.; Bell, S. J.; Hickey, A. J. Evaluation of novel particles as pulmonary delivery systems for insulin in rats. AAPS PharmSciTech 2003, 5 (2), 10-20.
75. Bhat, M. Development of a Novel Spray-Drying Technique To Produce Particles for Aerosol Delivery. In Respiratory Drug Delivery XIII; Dalby, R., Byron, P. R., Peart, J., Farr, S. J., Eds.; Davis Horwood International Publishing: Raleigh, NC, 2002; pp 427-429.
76. Blair, J.; Coghlan, D.; Langner, E.; Jansen, M.; Askey-Sarvar, A. Sustained Delivery of Insulin via the Lung Using Solidose Technology. In Respiratory Drug Delivery VIII; Dalby, R., Byron, P. R., Peart, J., Farr, S. J., Eds.; Davis Horwood International Publishing: Raleigh, NC, 2002; pp 411-414.
77. Cheng, Y. S.; Yazzie, D.; Gao, J.; Muggli, D.; Etter, J.; Rosenthal, G. J. Particle characteristics and lung deposition patterns in a human airway replica of a dry powder formulation of polylactic acid produced using supercritical fluid technology. J. Aerosol Med. 2003, 16 (1), 65-73. (Pubitemid 36457655)
78. Fiegel, J.; Ehrhardt, C.; Schaefer, U. F.; Lehr, C. M.; Hanes, J. Large porous particle impingement on lung epithelial cell monolayers - toward improved particle characterization in the lung. Pharm. Res. 2003, 20 (5), 788-796. (Pubitemid 36515312)
79. Bittner, B.; Kissel, T. Ultrasonic atomization for spray drying: a versatile technique for the preparation of protein loaded biodegradable microspheres. J. Microencapsul. 1999, 16 (3), 325-341. (Pubitemid 29191816)
80. Plowman, S.; Langner, E.; Blair, J. Elucidation of Insulin Release Mechanism from OED Microparticles Using ATR-FTIR. In Respiratory Drug Delivery VIII; Dalby, R., Byron, P. R., Peart, J., Farr, S. J., Eds.; Davis Horwood International Publishing: Raleigh, NC, 2002; pp 423-426.
81. Takeuchi, H.; Yamamoto, H.; Kawashima, Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv. Drug Deliv. Rev. 2001, 47 (1), 39-54. (Pubitemid 32209231)
82. Bruck, A.; Abu-Dahab, R.; Borchard, G.; Schafer, U. F.; Lehr, C. M. Lectin functionalized liposomes for pulmonary drug delivery: interaction with human alveolar epithelial cells. J. Drug Target. 2001, 9 (4), 241-251.
83. Abu-Dahab, R.; Schafer, U. F.; Lehr, C. M. Lectin-functionalized liposomes for pulmonary drug delivery: effect of nebulization on stability and bioadhesion. Eur. J Pharm. Sci. 2001, 14 (1), 37-46.
84. Yanagihara, K.; Cheng, P. W. Lectin enhancement of the lipofection efficiency in human lung carcinoma cells. Biochim. Biophys. Acta 1999, 1472 (1-2), 25-33.
85. Fajac, I,; Briand, P.; Monsigny, M.; Midoux, P. Sugar-mediated uptake of glycosylated polylysines and gene transfer into normal and cystic fibrosis airway epithelial cells. Hum. Gene Ther. 1999, 10 (3), 395-406.
86. Fajac, I.; Thévenot, G.; Bédouet, L.; Danel, C.; Riquet, M.; Merten, M.; Figarella, C.; Ava-Santucci, J. D.; Monsigny, M.; Briand, P. Uptake of plasmid/glycosylated polymer complexes and gene transfer efficiency in differentiated airway epithelial cells. J. Gene Med. 2003, 5 (1), 38-48. (Pubitemid 40310366)
87. Allo, J. C.; Midoux, P.; Merten, M.; Souil, E.; Lipecka, J.; Figarella, C.; Monsigny, M.; Briand, P.; Fajac, I. Efficient gene transfer into human normal and cystic fibrosis tracheal gland serous cells with synthetic vectors. Am. J. Respir. Cell Mol. Biol. 2000, 22 (2), 166-175. (Pubitemid 30351479)
88. Fajac, I.; Grosse, S.; Briand, P.; Monsigny, M. Targeting of cell receptors and gene transfer efficiency: a balancing act. Gene Ther. 2002, 9 (11), 740-742. (Pubitemid 34591478)
89. Robbins, J. C.; Lam, M. H.; Tripp, C. S.; Bugianesi, R. L.; Ponpipom, M. M.; Shen, T. Y. Synthetic glycopeptide substrates for receptor-mediated endocytosis by macrophages. Proc. Natl Acad. Sci. USA 1981, 78 (12), 7294-7298.
90. Derrien, D.; Midoux, P.; Petit, C.; Nègre, E.; Mayer, R.; Monsigny, M.; Roche, A. C. Muramyl dipeptide bound to poly-L-lysine substituted with mannose and gluconoyl residues as macrophage activators. Glycoconj. J. 1989, 6 (2), 241-255. (Pubitemid 19157908)
91. Liang, W. W.; Shi, X.; Deshpande, D.; Malanga, C. J.; Rojanasakul, C. J. Oligonucleotide targeting to alveolar macrophages by mannose receptormediated endocytosis. Biochim. Biophys. Acta 1996, 1279 (2), 227-234.
92. Briscoe, P.; Caniggia, I.; Graves, A.; Benson, B.; Huang, L.; Tanswell, A. K.; Freeman, B. A. Delivery of superoxide dismutase to pulmonary epithelium via pH-sensitive liposomes. Am. J. Physiol. 1995, 268, L374-L380.
93. Ross, G. F.; Morris, R. E.; Ciraolo, G.; Huelsman, K.; Bruno, K.; Whitsett, J. A.; Baatz, J. E.; Korfhagen, T. R. Surfactant protein A-polylysine conjugates for delivery of DNA to airway cells in culture. Hum. Gene Ther. 1995, 6 (1), 31-40.
94. Walther, F. J.; David-Cu, R.; Supnet, M. C.; Longo, M. L; Fan, B. R.; Bruni, R. Uptake of antioxidants in surfactant liposomes by cultured alveolar type II cells is enhanced by SP-A. Am. J. Physiol. 1993, 265 (4 Pt 1), L330-L339.
95. Frederiksen, K. S.; Abrahamsen, N.; Cristiano, R. J.; Damstrup, L.; Poulsen, H. W. Gene delivery by an epidermal growth factor/DNA polyplex to small cell lung cancer cell lines expressing low levels of epidermal growth factor receptor. Cancer Gene Ther. 2000, 7 (2), 262-268.
96. Cristiano, R. J.; Roth, J. A. Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor. Cancer Gene Ther. 1996, 3 (1), 4-10.
97. Yanagihara, K.; Cheng, H.; Cheng, P. W. Effects of epidermal growth factor, transferrin, and insulin on lipofection efficiency in human lung carcinoma cells. Cancer Gene Ther. 2000, 7 (1), 59-65.
98. Gladysheva, I. P.; Moroz, N. A.; Karmakova, T. A.; Nemtsova, E. R.; Yakubovskaya, R. I.; Larionova, N. I. Immunoconjugates of soybean Bowman-Birk protease inhibitor as targeted antitumor polymeric agents. J. Drug Target. 2001, 9 (5), 303-316. (Pubitemid 33094550)
99. Mastrobattista, E.; Storm, G.; van Bloois, L.; Reszka, R.; Bloemen, R. P. G.; Crommelin, D. J. A.; Henricks, P. J. A. Cellular uptake of liposomes targeted to intercellular adhesion molecule- 1 (ICAM-1) on bronchial epithelial cells. Biochim. Biophys. Acta 1999, 1419 (2), 353-363.
100. Scott, E. S.; Wiseman, J. W.; Evans, M. J.; Colledge, W. H. Enhanced gene delivery to human airway epithelial cells using an integrin-targeting lipoplex. J. Gene Med. 2001, 3 (2), 125-134. (Pubitemid 33685439)
101. Torchilin, V. P. TAT peptide-modified liposomes for intracellular delivery of drugs and DNA. Cell Mol. Biol. Lett. 2002, 7 (2), 265-267.
102. Wu, M.; Pasula, R.; Smith, P. A.; Martin, W. J. Mapping alveolar binding sites in vivo using phage peptide libraries. Gene Ther. 2003, 10 (17), 1429-1436.
103. Kreda, S. M.; Pickles, R. J.; Lazarowski, E. R.; Boucher, R. C. G-protein coupled receptors as targets for gene transfer vectors using natural smallmolecule ligands. Nat. Biotechnol. 2000, 18 (6), 635-640. (Pubitemid 30415297)
104. Goren, D.; Horowitz, A. T.; Tzemach, D.; Tarshish, M.; Zalipsky, S.; Gabizon, A. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin. Cancer Res. 2000, 6 (5), 1949-1957. (Pubitemid 30305094)
105. Reddy. J. A.; Low, P. S. Folate-mediated targeting of therapeutic and imaging agents to cancers. Crit. Rev. Ther. Drug Carrier Syst. 1998, 15 (6), 587-627. (Pubitemid 29006581)
106. Deshpande, D.; Toledo-Velasquez, D.; Wang, L. Y.; Malanga, C. J.; Ma, J. K.; Rojanasakul, Y. Receptor-mediated peptide delivery in pulmonary epithelial monolayers. Pharm. Res. 1994, 11 (8), 1121-1126. (Pubitemid 24259851)
107. Rudolph, C.; Schillinger, U.; Plank, C.; Gessner, A.; Nicklaus, P.; Müller, R.; Rosenecker, J. Non-viral gene delivery to the lung with copolymer-protected and transferrin-modified polyethylenimine. Biochim. Biophys. Acta 2002, 1573 (1), 75-83. (Pubitemid 35279791)
108. Unger, E. C.; Zutshi, R.; Matsunaga, T. O.; Ramaswami, R. Lipid-Coated Submicron-Sized Particles as Drug Carriers. In Nanoparticulates as Drug Carriers; Torchilin, V. P., Ed.; Imperial College Press: London, 2006; pp 248-249.
109. Smola, M.; Vandamme, T.; Sokolowski, A. Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases. International Journal of Nanomedicine 2008, 3 (1), 1-19. (Pubitemid 351517072)
110. Cindy, H. Inhalation: going beyond asthma! Drug Del. Technol. 2010, 10 (3), 35-42.
111. Pilcer, G.; Vanderbist, F.; Amighi, K. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery. Int. J. Pharm. 2009, 365 (1-2), 162-169.
112. Shaikh, S.; Nazim, S.; Shaikh, A.; Khan, T. Recent trends in applications of pulmonary drug delivery: a review. Int. J. of Pharma Res. & Development. 2011, 2 (12), 171-180.
113. Muttil, P.; Wang, C.; Hickey, A. Inhaled drug delivery for tuberculosis therapy. Pharm. Res. 2009, 26 (11), 2401-2416.